Cardinal Health, Inc.

CAH Healthcare Medical Distribution

Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

254.06 0.35 +0.14%
Market cap
$58.8B
P/E
35.0×
Fwd P/E
23.3×
Dividend yield
0.81%
F-score
7/9
Altman Z
5.09
Beneish M
−2.74
Dividend safety
86/100
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17
Piotroski F-Score
7 6 6 7 5 8 6 7 6 4
P/E ratio
32.72 25.93 28.62 93.63 0.00 27.32 0.00 10.50 64.67 19.15
Altman Z-Score
5.09 4.73 5.39 5.08 4.34 4.05 3.76 4.20 3.92 4.25
P/S ratio
0.22 0.18 0.11 0.12 0.08 0.10 0.10 0.10 0.11 0.19
Altman Z″-Score (non-manufacturers)
(0.22) (0.03) (0.02) 0.00 0.23 0.71 (0.16) 1.22 0.86 2.14
P/FCF ratio
12.31 21.85 7.34 10.45 5.17 8.22 9.64 5.96 6.45 30.99
P/Operating CF
33.13 26.64 11.50 28.60 4.79 25.07 63.72 28.20 27.77 34.12
Beneish M-Score
(2.74) (2.32) (2.67) (2.74) (2.77) (2.59) (3.11) (2.50) (2.74) (2.44)
Dividend Safety Score
86 — — — — — — — — —
P/B ratio
0.00 0.00 0.00 0.00 0.00 9.29 8.53 2.25 2.54 3.62
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.24 0.20 0.11 0.12 0.08 0.12 0.13 0.14 0.17 0.22
EV/EBITDA
16.84 14.73 12.24 17.53 178.60 15.54 0.00 6.46 19.55 9.95
EV/Operating CF
11.61 18.83 6.36 8.90 4.78 8.03 9.84 7.26 8.18 23.83
EV/FCF
13.19 24.36 7.33 10.71 5.39 9.61 12.16 8.26 9.49 35.40
Quick Ratio
0.43 0.44 0.48 0.45 0.50 0.45 0.47 0.46 0.42 0.70
Current Ratio
0.88 0.94 0.98 1.00 1.08 1.12 1.10 1.07 1.07 1.34
Net Debt/EBITDA
1.13 1.52 (0.02) 0.43 7.04 2.25 (1.26) 1.80 6.26 1.24
Debt/Assets
15.51% 16.05% 11.29% 10.84% 12.11% 14.03% 16.62% 19.61% 22.56% 25.91%
Debt/Equity
(3.26) (3.24) (1.59) (1.59) (7.53) 3.48 3.78 1.27 1.49 1.52
Asset Turnover
4.61 4.53 5.13 4.70 4.11 3.81 3.74 3.60 3.42 3.50
Operating CF/Net income
3.02 1.54 4.42 8.62 (3.38) 3.98 (0.53) 2.00 10.81 0.92
Capex/Depreciation
(0.65) (0.69) (0.70) (0.70) (0.51) (0.51) (0.41) (0.33) (0.37) (0.54)
Interest Coverage
7.51 10.58 24.37 8.95 (4.13) 2.62 (17.22) 7.01 0.38 10.55
ROE
(63.98%) (53.40%) (27.62%) (18.02%) (172.43%) 34.08% (91.01%) 22.00% 3.97% 19.23%
ROA
3.10% 3.18% 1.93% 0.76% (2.12%) 1.43% (9.04%) 3.37% 0.64% 3.47%
ROIC
125.05% 70.42% 0.00% 0.00% 0.00% 6.38% (44.19%) 10.88% 0.59% 12.81%
Return on Tangible Assets
(80.85%) 467.37% 48.05% 13.43% (19.76%) 10.56% (78.79%) 34.13% 6.17% 14.31%
Average Days of Receivables
19.83 21.72 19.45 19.78 21.26 20.45 19.72 21.19 20.81 22.60
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.52% 2.47% 2.20% 2.34% 2.49% 2.79% 2.99% 3.08% 3.36% 2.90%
Intangible Assets out of Total Assets
0.24 0.23 0.14 0.14 0.17 0.23 0.28 0.29 0.31 0.23
Share Based Compensation of Revenue
0.14% 0.11% 0.05% 0.05% 0.04% 0.05% 0.06% 0.06% 0.06% 0.07%
Graham Net Nets
(0.38) (0.48) (0.56) (0.51) (0.80) (0.70) (0.85) (0.62) (0.61) (0.20)
Graham Number
0.00 0.00 0.00 0.00 13.98 17.00 0.00 46.37 18.19 44.41
Earnings Yield
3.06% 3.86% 3.49% 1.07% (6.57%) 3.66% (23.86%) 9.52% 1.55% 5.22%
Free Cash Flow Yield
8.13% 4.58% 13.62% 9.57% 19.33% 12.17% 10.38% 16.78% 15.50% 3.23%
Revenue per Share
1,077.32 923.56 925.82 785.36 649.91 556.39 521.92 485.11 437.09 410.02
Operating CF per Share
21.92 9.95 15.36 10.90 11.38 8.32 6.69 9.07 8.84 3.74
Capex per Share
(2.62) (2.26) (2.04) (1.84) (1.28) (1.37) (1.27) (1.09) (1.23) (1.22)
Free Cash Flow per Share
19.31 7.69 13.32 9.05 10.10 6.95 5.42 7.98 7.62 2.51
Cash per Share
20.58 16.07 20.95 15.62 16.91 11.67 9.46 8.44 5.63 21.70
Shareholders Equity per Share
(11.54) (10.93) (13.11) (11.33) (2.53) 6.14 6.12 21.10 19.36 21.54
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(11.54) (10.93) (13.11) (11.33) (2.53) 6.14 6.12 21.10 19.36 21.54
Free Cash Flow
4,556.00 1,853.00 3,263.00 2,363.00 2,819.00 2,029.00 1,587.00 2,394.00 2,384.00 797.00
Working Capital
(5,151.00) (2,524.00) (756.00) (3.00) 2,385.00 3,424.00 2,325.00 1,638.00 1,660.00 7,124.00
Capital Expenditures
(618.00) (544.00) (499.00) (481.00) (356.00) (400.00) (373.00) (328.00) (384.00) (387.00)
Net Current Asset Value
(21,270.00) (19,383.00) (13,449.00) (12,569.00) (11,649.00) (11,611.00) (13,034.00) (8,886.00) (9,339.00) (4,939.00)
EV/EBIT
23.00 19.84 19.24 33.65 0.00 41.31 0.00 9.60 179.63 13.31
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
21.46 17.80 19.27 32.82 0.00 35.32 0.00 6.93 122.09 11.65
Other line items
Depreciation/Fixed assets
0.32 0.28 0.28 0.28 0.29 0.33 0.39 0.42 0.42 0.38
Cash ROIC
41.35% 18.97% 46.53% 40.60% 30.23% 17.74% 14.00% 14.17% 14.16% 3.31%
Accounts Receivable Turnover
18.79 17.58 19.56 18.92 18.44 18.71 18.30 17.91 17.27 16.82
Accounts Payable Turnover
6.70 6.45 7.11 6.94 6.88 6.91 6.81 6.73 6.90 7.01
Inventory Turnover
14.33 13.49 14.12 12.48 11.57 11.20 11.23 11.04 10.98 11.26
Average Days of Payables
57.16 59.09 52.83 55.15 56.63 55.56 53.42 56.67 55.41 52.95
Days of Inventory on Hand
25.82 28.65 24.88 29.70 32.64 34.21 32.98 33.74 34.66 33.42
Average Receivables
13,528.50 12,663.00 11,596.00 10,834.50 9,832.00 8,683.50 8,356.00 8,124.00 7,924.00 7,726.50
Average Payables
36,498.00 33,236.00 30,846.50 28,531.00 25,414.00 22,537.00 21,454.50 20,606.00 18,791.50 17,606.00
Average Inventory
17,064.00 15,894.00 15,538.00 15,877.50 15,115.00 13,896.00 13,010.00 12,565.00 11,804.50 10,958.00
Average Assets
55,210.50 49,121.50 44,235.00 43,613.50 44,165.50 42,609.50 40,864.50 40,457.00 40,031.50 37,117.00
Average Common Equity
(2,679.00) (2,923.00) (3,084.50) (1,831.50) 544.00 1,793.00 4,061.00 6,194.50 6,443.50 6,699.50

Fold the line items

Columns are period end dates